SLN.L

Silence Therapeutics Plc
Silence Therapeutics - Holding(s) in Company
28th October 2021, 15:02
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 6285Q
Silence Therapeutics PLC
28 October 2021
 

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer  and to the FCA in Microsoft  Word format if possible) i

 

1a. Identity of the issuer or the underlying issuer

of existing shares to which voting rights are

attached ii:

Silence Therapeutics plc

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments


An event changing the breakdown of voting rights


Other (please specify) iii:


3. Details of person subject to the notification obligation  iv

Name

LOIM Lombard Odier Asset Management (Europe) Limited

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s)  (if different from 3.) v

Name


City and country of registered office (if applicable)


5. Date on which the threshold was crossed or  reached vi:

25/10/2021

6. Date on which issuer notified (DD/MM/YYYY):

26/10/2021

7. Total positions of person(s) subject to the notification obligation


% of voting rights attached to shares (total of 8. A)

% of voting rights  through financial instruments  (total of 8.B 1 + 8.B 2)

Total of both in %  (8.A + 8.B)

Total number of  voting rights of issuer vii

Resulting situation  on the date on which threshold was  crossed or reached

8.84%

2.17%

11.01%

89,777,000

Position of previous  notification (if  applicable)

5.94%

4.20%

10.14%


 

 

 

ISIN CODE (if possible)

 

GB00B9GTXM62   Ordinary

SUBTOTAL 8. A

8. Notified details of the resulting situation on the date on which the threshold was crossed or  reached viii

A: Voting rights attached to shares

Class/type of

shares

ISIN CODE (if possible)

 

Number of voting rights ix

% of  voting rights

Direct(Art 9 of Directive  2004/109/EC) (DTR5.1)

Indirect(Art 10 of Directive  2004/109/EC) (DTR5.2.1)

Direct(Art 9 of Directive  2004/109/EC) (DTR5.1)

Indirect(Art 10 of Directive  2004/109/EC) (DTR5.2.1)

GB00B9GTXM62   Ordinary


7,935,940


8.84%

SUBTOTAL 8. A

7,935,940

8.84%

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

 

Type of financial

instrument

 

 

Expiration

date x

 

 

Exercise/

Conversion Period xi

 

Number of voting rights

that may be acquired if

the instrument is

exercised/converted.

% of voting rights

ADR US82686Q1013



1,951,032

2.17%


SUBTOTAL 8. B 1

1,951,032

2.17%

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive  2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration  date x

Exercise/

Conversion Period xi 

Physical or  cash  settlement xii

Number of  voting rights

% of voting rights




CASH




SUBTOTAL  8.B.2



 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not  control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer     xiii

x

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity     xiv  (please add additional rows as necessary)


Name xv

% of voting rights if it  equals or is higher  than the notifiable  threshold

% of voting rights  through financial instruments if it equals  or is higher than the  notifiable threshold

Total of both if it  equals or is higher  than the notifiable  threshold









 

 

10. In case of proxy voting, please identify:

Name of the proxy holder


The number and % of voting rights held



The date until which the voting rights will be held


 

 

11. Additional information xvi


 

Place of completion

London

Date of completion

26/10/2021

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUWRVRARURUAA ]]>
TwitterFacebookLinkedIn